Druckversion

AASLD: Long-Term Outcomes Better With SVR (CME/CE)


BOSTON -- Achieving sustained virologic response after treatment for hepatitis C is a boon to patients even 20 years down the road, researchers said here. In a cohort of patients who started treatment at the National Institutes of Health in 1984, none... full story

Source: medpagetoday